Dehydroabietic acid derivative QC2 induces oncosis in hepatocellular carcinoma cells

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhang, Guang ^a   Jiang, Chunping ^a   Wang, Zhongxia ^a,b   Chen, Weibo ^a,b   Gu, Wen ^c   Ding, Yitao ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NANJING UNIVERSITY   (China)

^c NANJING FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALPAIN; DEHYDROABIETIC ACID; LACTATE DEHYDROGENASE; ABIETANE DERIVATIVE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; PEPTIDE CHLOROMETHYL KETONE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL SWELLING; CYTOSKELETON; CYTOTOXICITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; LIVER CELL; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; SYNTHESIS; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; AMINO ACID CHLOROMETHYL KETONES; CALPAIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE INHIBITORS; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE; CYTOSKELETON; DITERPENES, ABIETANE; HEPATOCYTES; HUMANS; IMIDAZOLES; INDOLES; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; REACTIVE OXYGEN SPECIES;

EID: 84904808263     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/682197     Document Type: Article

References (33)

1. Schütte K., Bornschein J., Malfertheiner P., Hepatocellular carcinoma-epidemiological trends and risk factors. Digestive Diseases 2009 27 2 80 92 10.1159/000218339 2-s2.0-67650938576
2. Blechacz B., Mishra L., Hepatocellular carcinoma biology. Recent Results in Cancer Research 2013 190 1 20 10.1007/978-3-642-16037-0-1 2-s2.0-84868329935
3. Bruix J., Sherman M., Management of hepatocellular carcinoma: an update. Hepatology 2011 53 3 1020 1022 10.1002/hep.24199 2-s2.0-79952231921
4. Llovet J. M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J., De Oliveira A. C., Santoro A., Raoul J., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T. F., Galle P. R., Seitz J., Borbath I., Häussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J., Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 2008 359 4 378 390 10.1056/NEJMoa0708857 2-s2.0-47949116252
5. Cheng A., Kang Y., Chen Z., Tsao C., Qin S., Kim J. S., Luo R., Feng J., Ye S., Yang T., Xu J., Sun Y., Liang H., Liu J., Wang J., Tak W. Y., Pan H., Burock K., Zou J., Voliotis D., Guan Z., Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. The Lancet Oncology 2009 10 1 25 34 10.1016/S1470-2045(08)70285-7 2-s2.0-57749189578
6. Ng I. O. L., Liu C. L., Fan S. T., Ng M., Expression of P-glycoprotein in hepatocellular carcinoma: a determinant of chemotherapy response. The American Journal of Clinical Pathology 2000 113 3 355 363 10.1309/AC1M-4TY4-U0TN-EN7T 2-s2.0-0034100195 (Pubitemid 30217382)
7. Newman D. J., Cragg G. M., Snader K. M., The influence of natural products upon drug discovery. Natural Product Reports 2000 17 3 215 234 10.1039/a902202c 2-s2.0-0034082239 (Pubitemid 30390787)
8. Tanaka R., Tokuda H., Ezaki Y., Cancer chemopreventive activity of "rosin" constituents of Pinus spez. and their derivatives in two-stage mouse skin carcinogenesis test. Phytomedicine 2008 15 11 985 992 10.1016/j.phymed.2008.02.020 2-s2.0-53849094775
9. Gu W., Wu R., Qi S., Gu C., Si F., Chen Z., Synthesis and antibacterial evaluation of new N-acylhydrazone derivatives from dehydroabietic acid. Molecules 2012 17 4 4634 4650 10.3390/molecules17044634 2-s2.0-84860247230
10. Gu W., Qiao C., Wang S. F., Hao Y., Miao T. T., Synthesis and biological evaluation of novel N-substituted 1H-dibenzo[a, c]carbazole derivatives of dehydroabietic acid as potential antimicrobial agents. Bioorganic Medicinal Chemistry Letters 2014 24 1 328 331 10.1016/j.bmcl.2013.11.009
11. Ding X., Wu J., Jiang C., ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sciences 2010 86 17-18 631 637 10.1016/j.lfs.2010.02.012 2-s2.0-77951224759
12. Salvesen G. S., Caspases: opening the boxes and interpreting the arrows. Cell Death and Differentiation 2002 9 1 3 5 10.1038/sj.cdd.4400963 2-s2.0-0036144378 (Pubitemid 34071988)
13. Ribault L., Gournier J. P., Barthe B. L., Volvulus of the pelvic colon. Apropos of 59 cases in the western Africa savannah area Chirurgie; Mémoires de l'Académie de Chirurgie 1989 115 2 78 83 (Pubitemid 19220995)
14. Degterev A., Hitomi J., Germscheid M., Ch'en I. L., Korkina O., Teng X., Abbott D., Cuny G. D., Yuan C., Wagner G., Hedrick S. M., Gerber S. A., Lugovskoy A., Yuan J., Identification of RIP1 kinase as a specific cellular target of necrostatins. Nature Chemical Biology 2008 4 5 313 321 10.1038/nchembio.83 2-s2.0-42249102086 (Pubitemid 351550892)
15. Liu X., van Vleet T., Schnellmann R. G., The role of calpain in oncotic cell death. Annual Review of Pharmacology and Toxicology 2004 44 349 370 10.1146/annurev.pharmtox.44.101802.121804 2-s2.0-1342281236 (Pubitemid 38263845)
16. Llovet J. M., Real M. I., Montaña X., Planas R., Coll S., Aponte J., Ayuso C., Sala M., Muchart J., Solà R., Rodés J., Bruix J., Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. The Lancet 2002 359 9319 1734 1739 10.1016/S0140-6736(02)08649-X 2-s2.0-0037129704 (Pubitemid 34607087)
17. Lo C., Ngan H., Tso W., Liu C., Lam C., Poon R. T., Fan S., Wong J., Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 5 1164 1171 10.1053/jhep.2002.33156 2-s2.0-0036237822 (Pubitemid 34454013)
18. Majno G., Joris I., Apoptosis, oncosis, and necrosis: an overview of cell death. The American Journal of Pathology 1995 146 1 3 15 2-s2.0-0028891783
19. Weerasinghe P., Buja L. M., Oncosis: an important non-apoptotic mode of cell death. Experimental and Molecular Pathology 2012 93 3 302 308 10.1016/j.yexmp.2012.09.018 2-s2.0-84870702650
20. Petersen M., Hofius D., Andersen S. U., Signaling unmasked: autophagy and catalase promote programmed cell death. Autophagy 2014 10 3 520 521
21. Trump B. F., Berezesky I. K., Calcium-mediated cell injury and cell death. The FASEB Journal 1995 9 2 219 228 2-s2.0-0028946358
22. Liu X., Schnellmann R. G., Calpain mediates progressive plasma membrane permeability and proteolysis of cytoskeleton-associated paxillin, talin, and vinculin during renal cell death. Journal of Pharmacology and Experimental Therapeutics 2003 304 1 63 70 10.1124/jpet.102.043406 2-s2.0-0037214421 (Pubitemid 36008913)
23. Lieberthal W., Menza S. A., Levine J. S., Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. The American Journal of Physiology-Renal Physiology 1998 274 2, part 2 F315 F327 2-s2.0-0031989121
24. Trump B. F., Berezesky I. K., Chang S. H., Phelps P. C., The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicologic Pathology 1997 25 1 82 88 10.1177/019262339702500116 2-s2.0-0031047146 (Pubitemid 27100564)
25. Ma L. S., Jiang C. Y., Cui M., Lu R., Liu S., Zheng B., Li L., Li X., Fluopsin C induces oncosis of human breast adenocarcinoma cells. Acta Pharmacologica Sinica 2013 34 8 1093 1100 10.1038/aps.2013.44 2-s2.0-84882332714
26. Ji Y. B., Gao S. Y., Ji C. F., Zou X., Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein. Journal of Ethnopharmacology 2008 115 2 194 202 10.1016/j.jep.2007.09.023 2-s2.0-37249089342 (Pubitemid 350266263)
27. Sun L., Zhao Y., Yuan H., Li X., Cheng A., Lou H., Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells. Cancer Chemotherapy and Pharmacology 2011 67 4 813 821 10.1007/s00280-010-1387-9 2-s2.0-79954448902
28. Zhou X., Sun W., Wang W., Chen K., Zheng J., Lu M., Li P., Zheng Z., Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo. Anti-Cancer Drugs 2013 24 9 920 927 10.1097/CAD.0b013e328364a109 2-s2.0-84883432719
29. Moran J. H., Schnellmann R. G., Diverse cytoprotectants prevent cell lysis and promote recovery of respiration and ion transport. Biochemical and Biophysical Research Communications 1997 234 1 275 277 10.1006/bbrc.1997.6625 2-s2.0-0030918136 (Pubitemid 27267573)
30. Liu X., Rainey J. J., Harriman J. F., Schnellmann R. G., Calpains mediate acute renal cell death: role of autolysis and translocation. The American Journal of Physiology-Renal Physiology 2001 281 4 F728 F738 2-s2.0-0034785810
31. Molinari M., Anagli J., Carafoli E., Ca2+-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. Journal of Biological Chemistry 1994 269 45 27992 27995 2-s2.0-0028171412
32. Kulkarni S., Saido T. C., Suzuki K., Fox J. E. B., Calpain mediates integrin-induced signaling at a point upstream of rho family members. The Journal of Biological Chemistry 1999 274 30 21265 21275 10.1074/jbc.274.30.21265 2-s2.0-0033597821 (Pubitemid 29350597)
33. Yamanaka N., Okamoto E., Kawamura E., Kato T., Oriyama T., Fujimoto J., Furukawa K., Tanaka T., Tomoda F., Tanaka W., Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993 18 1 79 85 10.1002/hep.1840180114 2-s2.0-0027192875 (Pubitemid 23193621)